Turtle Creek Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.4M Buy
136,660
+1,090
+0.8% +$503K 2.83% 19
2026
Q1
$65.1M Buy
135,570
+132,770
+4,742% +$68M 2.44% 19
2025
Q4
$1.57M Sell
2,800
-2,000
-42% -$1.14M 0.07% 32
2025
Q3
$2.47M Sell
4,800
-6,200
-56% -$2.71M 0.07% 33
2025
Q2
$3.45M Buy
+11,000
New +$3.3M 0.1% 31

Other funds holding MEDP

Turtle Creek Asset Management's MEDP Position: Q2 2026 in Review

Turtle Creek Asset Management increased its Medpace (MEDP) stake by 0.8% in Q2 2026, buying an estimated $503K and bringing the position to 136,660 shares worth $72.4M. The position accounts for 2.83% of the portfolio, ranked #19.

Turtle Creek Asset Management first reported a position in MEDP in Q2 2025 and has held it in 5 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Turtle Creek Asset Management held 136,660 shares of Medpace worth $72.4M as of Q2 2026.
  • Turtle Creek Asset Management bought 1,090 Medpace shares in Q2 2026, an estimated $503K.
  • Medpace made up 2.83% of Turtle Creek Asset Management's portfolio in Q2 2026, its #19 holding.
  • Turtle Creek Asset Management first reported a position in Medpace in Q2 2025 and has held it in 5 quarters since.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Turtle Creek Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.